FP/SAL

DRUG2 trials

Sponsors

Research in Real-Life Ltd, GlaxoSmithKline

Conditions

Asthma

Phase 3

Effectiveness of Fluticasone Furoate/ Umeclidinium/ Vilanterol (FF/UMEC/VI) Using the Connected Inhaler System (CIS) as Compared With Fluticasone Proprionate/ Salmeterol (FP/SAL) Plus Tiotropium (TIO) in Inadequately Controlled Asthma

WithdrawnNCT03376932

GlaxoSmithKlineAsthma

Start: 2019-01-18End: 2021-02-03Updated: 2019-03-25

Unknown Phase

Real-world Effectiveness of Combination Therapies in Primary Care Asthma Management

CompletedNCT01908075

Research in Real-Life LtdAsthma

Start: 2011-01-31End: 2013-03-31Updated: 2013-07-25